Goldman Sachs Projects Crude Oil May Surge to $120 Amid Growing Middle East Mari...
Goldman Sachs projects oil could reach $120/barrel amid Middle East shipping attacks. Brent crude trades at $97.55 as Strait of Ho...
DBS and Citi complete weekend USD payment via Swift’s Digital Ledger using toke...
The transaction is the second confirmed live use of Swift's blockchain ledger, coming as the network races to prove it can compete...
Markets Brace for CPI Data, Oracle (ORCL) Earnings, and Apple Product Launch
This week brings crucial inflation data, Oracle earnings, record diesel prices, and Apple's iPhone 18 event. Here's what investors...
AI Boom Propels Samsung and SK Hynix to Record Gains as Memory Chip Market Explo...
Samsung and SK Hynix shares soared Monday as DRAM revenue climbed 59.5% to $154.73B in Q2 2026, driven by AI demand and limited su...
SpaceX (SPCX) Stock Gains Momentum as Starship Era Begins: Analysts Project 50%...
SpaceX (SPCX) stock analysis: 80th Starlink launch complete, Starship transition underway, Q2 revenue up 92%, and analysts target...
SanDisk (SNDK) Stock Soars 12% Following S&P 100 Index Addition Announcement
SanDisk (SNDK) stock surged 12% on S&P 100 addition news. Company secured $93.9B in supply contracts and posted 633% YTD gains ami...
Gold Slips Under $4,400 as Robust Employment Data Strengthens Fed Hike Expectati...
Gold drops below $4,400 after robust August jobs data raises Fed rate hike odds to 60%. Inflation reports due this week could shap...
Harmony Price Prediction 2026, 2027-2030: ONE Token Outlook and Future Targets
The post Harmony Price Prediction 2026, 2027-2030: ONE Token Outlook and Future Targets appeared first on Coinpedia Fintech News S...
Ripple Returns to Korea as Major XRP Company Awaits Nasdaq Listing
XRP holds near $1.40 as Ripple's ecosystem expands into Korea and Evernorth eyes a Nasdaq listing. Key levels, scenarios, and an e...
Novartis (NVS) Stock Drops 3% as Pelacarsen Heart Drug Disappoints in Key Trial
Novartis (NVS) stock dropped 3% after pelacarsen failed its cardiovascular outcomes trial, raising concerns about Lp(a)-targeting...